Professor, Medicine, Brown University Program in Medicine
Hematology
Dr. Peter J. Quesenberry, MD
|
|
Give Review
Peter Quesenberry works in the field of Hematology. He studied medicine at University of Virginia School of Medicine. Peter Quesenberry is also a published physician. He has 57 publication published. The most recent publication is: A stem cell apostasy: A tale of 4 H words. Peter Quesenberry accepts all Medicare patients.
Publications
- A stem Cell apostasy: A tale of 4 H words.
- Cellular Phenotype and ExtraCellular Vesicles: Basic and Clinical Considerations.
- Advances in cellular therapy for the treatment of Leukemia.
- The murine long-term multi-lineage renewal marrow stem Cell is a cycling Cell.
- Induction of pulmonary hypertensive changes by extraCellular vesicles from monocrotaline-treated mice.
- Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.
- Heterogeneity of Colorectal Cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
- Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic Cells.
- Progenitor/stem Cell fate determination: interactive dynamics of Cell cycle and microvesicles.
- Marrow cell genetic phenotype change induced by human lung Cancer cells.
- Expression of Cell cycle-related genes with cytokine-induced Cell cycle progression of primitive hematopoietic stem Cells.
- InterCellular transfer of proteins as identified by stable isotope labeling of amino acids in Cell culture.
- Heterogeneity of non-cycling and cycling synchronized murine hematopoietic stem/progenitor Cells.
- Marrow Cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.
- Nonengraftment haploidentical Cellular immunotherapy for refractory malignancies: tumor responses without chimerism.
- An interesting fishing expedition.
- The paradoxical dynamism of marrow stem Cells: considerations of stem Cells, niches, and microvesicles.
- Conversion potential of marrow cells into Lung cells fluctuates with cytokine-induced cell cycle.
- Gene expression fluctuations in murine hematopoietic stem Cells with Cell cycle progression.
- Alteration of marrow cell gene expression, protein production, and engraftment into Lung by Lung-derived microvesicles: a novel mechanism for phenotype modulation.
- Cryopreservation of hematopoietic stem Cells.
- The stem Cell continuum: Cell cycle, injury, and phenotype lability.
- Murine allogeneic in vivo stem Cell homing(,).
- Discrete stem Cells: subsets or a continuum?
- The continuum model of marrow stem Cell regulation.
- A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine Lymphoma.
- Stem Cells and pulmonary metamorphosis: new concepts in repair and regeneration.
- Critical variables in the conversion of marrow Cells to skeletal muscle.
- The stem Cell continuum.
- Developmental biology: Ignoratio elenchi: red herrings in stem Cell research.
- The stem Cell continuum: considerations on the heterogeneity and plasticity of marrow stem Cells.
- Lineage-negative bone marrow Cells travel bidirectionally in the olfactory migratory stream but maintain hematopoietic phenotype.
- Association of fetal hormone levels with stem cell potential: evidence for early life roots of human Cancer.
- Chromatin remodeling and stem Cell theory of relativity.
- Circadian variations of bone marrow engraftability.
- Intrinsic hematopoietic stem Cell/progenitor plasticity: Inversions.
- Differentiation hotspots: the deterioration of hierarchy and stochasm.
- Stem Cell plasticity: an overview.
- Targeting of Lin-Sca+ hematopoietic stem Cells with bispecific antibodies to injured myocardium.
- A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem Cells.
- Studies on BrdU labeling of hematopoietic Cells: stem Cells and Cell lines.
- Akt signaling regulates side population Cell phenotype via Bcrp1 translocation.
- Phase I/II study of treatment of stage IV breast Cancer with OKT3 x trastuzumab-armed activated T cells.
- Quantitative tissue stem Cell modeling.
- Future prospects for patient care utilizing autologous lymphoid and hematopoietic stem Cells.
- Marrow stem Cells shift gene expression and engraftment phenotype with Cell cycle transit.
- The chiaroscuro stem Cell: a unified stem Cell theory.
- Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy.
- Rhythmicity of engraftment and altered Cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures.
- Engraftment of post 5-fluorouracil murine marrow into minimally myeloablated (100 cGy) murine hosts.
- Transplanted clonal neural stem-like Cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus.
- Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian Carcinomas.
- The new stem Cell biology.
- Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate Cancer cell line upon extracellular vesicle exposure.
- RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon Cancer patients.
- Marrow Hematopoietic Stem Cells Revisited: They Exist in a Continuum and are Not Defined by Standard Purification Approaches; Then There are the Microvesicles.
Schools
Virginia Commonwealth University School Of Medicine
Boston University Hospital
Boston City Hospital
St Elizabeths Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Boston University Medical Center -
University of Virginia School of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1477551992 | |
| NPPES Provider LastName | QUESENBERRY | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 029034923 | |
| NPPES Provider State | RI | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 77.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477551992 |
| Last Name Of The Provider | QUESENBERRY |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Emmanuel Apor, MD |
|
|
Dr. Angela Taber, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin Kurtizky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara E. Barker, PHD |
|
|
Dr. Hussain M. Naseri, MD |
|
|
Dr. Ahmad S. Al-Homsi, MD |
|
|
Dr. Eric S. Winer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric P. Winer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary M. Strauss, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William Sikov, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ariel E. Birnbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ritesh Rathore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward G. Wittels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirela R. Stancu, MD
This Doctor is OpenDoctor Recommended.
|